drugset / Trial / NCT02967497

Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild Type

NCT02967497 ↗

RandomizedParallel-groupOpen-labelSupportive care

Summary

This randomized pilot phase II trial studies the effect of YQ1, a herbal medicine, with cisplatin-based chemotherapy on gut microbiota and immune response in patients with EGFR/ALK wild type non-small cell lung cancer, stage IIIB-IV.

Timeline

Start
2016-10
Primary completion
2017-09
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Subject YQ1 Traditional medicine (herbal / TCM) — Oral